Ms. Ramasastry is the managing partner of Life Sciences Advisory, LLC, an independent firm that she founded to provide strategic advice and business development solutions for life science companies.
Prior to founding Life Sciences Advisory, Ms. Ramasastry spent 10 years as an investment banker with Merrill Lynch & Company, where she helped establish the biotechnology practice and advised on mergers and acquisitions, and strategic and capital markets transactions.
Previously, she served as a financial analyst in mergers and acquisitions group at Wasserstein Perella & Co., an investment banking firm. Ms. Ramasastry currently serves on the board of directors for Vir Biotechnology Inc., Mirum Pharmaceuticals Inc., Akouos, Inc., Glenmark Pharmaceuticals Ltd., and Sangamo Therapeutics, Inc., and is also a health innovator fellow of the Aspen Institute and a member of the Aspen Global Leadership Network.
Ms. Ramasastry holds a B.A. in economics and an M.S. in management science and engineering from Stanford University, as well as an M. Phil. in management studies from the University of Cambridge.
What is Saira Ramasastry's net worth?
The estimated net worth of Saira Ramasastry is at least $261,128.25 as of June 21st, 2024. Ms. Ramasastry owns 40,485 shares of Day One Biopharmaceuticals stock worth more than $261,128 as of May 10th. This net worth estimate does not reflect any other investments that Ms. Ramasastry may own. Learn More about Saira Ramasastry's net worth.
How do I contact Saira Ramasastry?
The corporate mailing address for Ms. Ramasastry and other Day One Biopharmaceuticals executives is 395 OYSTER POINT BLVD STE 217, SOUTH SAN FRANCISCO CA, 94080. Day One Biopharmaceuticals can also be reached via phone at 650-484-0899 and via email at hans@lifesciadvisors.com. Learn More on Saira Ramasastry's contact information.
Has Saira Ramasastry been buying or selling shares of Day One Biopharmaceuticals?
Saira Ramasastry has not been actively trading shares of Day One Biopharmaceuticals during the last quarter. Most recently, Saira Ramasastry sold 10,000 shares of the business's stock in a transaction on Friday, June 21st. The shares were sold at an average price of $13.19, for a transaction totalling $131,900.00. Following the completion of the sale, the director now directly owns 40,485 shares of the company's stock, valued at $533,997.15. Learn More on Saira Ramasastry's trading history.
Who are Day One Biopharmaceuticals' active insiders?
Are insiders buying or selling shares of Day One Biopharmaceuticals?
During the last twelve months, insiders at the sold shares 19 times. They sold a total of 177,625 shares worth more than $2,563,738.23. The most recent insider tranaction occured on February, 18th when CEO Jeremy Bender sold 12,048 shares worth more than $144,094.08. Insiders at Day One Biopharmaceuticals own 6.2% of the company.
Learn More about insider trades at Day One Biopharmaceuticals. Information on this page was last updated on 2/18/2025.
